# Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs:  Guidance for Industry - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/assessing-adhesion-with-transdermal-and-topical-delivery-systems-for-andas-guidance-for-industry/2c6a5c99-ec56-4af1-a9c3-791ae292275e

> FDA guidance document: Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs:  Guidance for Industry. Issue date: July 31, 2026. Get complete insights and analysis.

---

## Details

- Title: Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-07-31
- Last Changed: 2026-07-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1254">FDA-2016-D-1254</a>

## Related Documents

- [Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs](https://www.keypedia.com/guidances/guidance-document/physicochemical-and-structural-q3-characterization-of-topical-drug-products-submitted-in-andas/9120d697-9a7d-4aac-b9ff-98ee81aafa56)
- [Pulmonary Tuberculosis: Developing Drugs for Treatment:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/pulmonary-tuberculosis-developing-drugs-for-treatment-guidance-for-industry/c3b04c05-0fb6-49b6-93c3-acb835649031)
- [Certain Postapproval Requirements and Resources for ANDAs](https://www.keypedia.com/guidances/guidance-document/certain-postapproval-requirements-and-resources-for-andas/114dc69b-dd6a-4c2f-88c6-0386cd92124f)